-
2
-
-
0037275143
-
The influence of sex on pharmacokinetics
-
Schwartz JB. The influence of sex on pharmacokinetics. Clin Pharmacokinet 2003;42:107-21.
-
(2003)
Clin Pharmacokinet
, vol.42
, pp. 107-121
-
-
Schwartz, J.B.1
-
4
-
-
14644407562
-
Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics
-
Anderson GD. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health 2005;14:19-29.
-
(2005)
J Womens Health
, vol.14
, pp. 19-29
-
-
Anderson, G.D.1
-
6
-
-
34347234652
-
-
Pharmacokinetic Studies in Man. Legislative basis Directive 75/318/EEC as amended 1987: 99-107.
-
Pharmacokinetic Studies in Man. Legislative basis Directive 75/318/EEC as amended 1987: 99-107.
-
-
-
-
7
-
-
34347259123
-
-
Brøsen K. Lægemidlers elimination. I: Kampmann JP, Brøsen K, Simonsen U, red. Basal og Klinisk Farmakologi. København: FADLs Forlag A/S 2007.
-
Brøsen K. Lægemidlers elimination. I: Kampmann JP, Brøsen K, Simonsen U, red. Basal og Klinisk Farmakologi. København: FADLs Forlag A/S 2007.
-
-
-
-
8
-
-
0024558679
-
Influence of gender and menopause on gastric emptying and motility
-
Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989;96:11-7.
-
(1989)
Gastroenterology
, vol.96
, pp. 11-17
-
-
Hutson, W.R.1
Roehrkasse, R.L.2
Wald, A.3
-
9
-
-
0035107449
-
The effect of rifampin administration on the disposition of fexofenadine
-
Hamman MA, Bruce MA, Haehner-Daniels BD et al. The effect of rifampin administration on the disposition of fexofenadine. Clin Pharmacol Ther 2001;69:114-21.
-
(2001)
Clin Pharmacol Ther
, vol.69
, pp. 114-121
-
-
Hamman, M.A.1
Bruce, M.A.2
Haehner-Daniels, B.D.3
-
10
-
-
14044276929
-
-
Paine MF, Ludington SS, Chen ML et al. Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression? Drug Metab Dispos 2005;33:426-33. Epub 2004 dec 17.
-
Paine MF, Ludington SS, Chen ML et al. Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression? Drug Metab Dispos 2005;33:426-33. Epub 2004 dec 17.
-
-
-
-
12
-
-
33750626722
-
The effect of gender on the pharmacokinetics of verapamil and norverapamil in human
-
Dadashzadeh S, Javadian B, Sadeghian S. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human. Biopharm Drug Dispos 2006;27:329-34.
-
(2006)
Biopharm Drug Dispos
, vol.27
, pp. 329-334
-
-
Dadashzadeh, S.1
Javadian, B.2
Sadeghian, S.3
-
13
-
-
0036667961
-
The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors
-
Rasmussen BB, Brix TH, Kyvik KO et al. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 2002;12:473-8.
-
(2002)
Pharmacogenetics
, vol.12
, pp. 473-478
-
-
Rasmussen, B.B.1
Brix, T.H.2
Kyvik, K.O.3
-
14
-
-
0024468418
-
Dose-related plasma levels of clozapine: Influence of smoking behaviour, sex and age
-
Haring C, Meise U, Humpel C et al. Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age. Psychopharmacology (Berl) 1989;99 Suppl:S38-40.
-
(1989)
Psychopharmacology (Berl)
, vol.99
, Issue.SUPPL.
-
-
Haring, C.1
Meise, U.2
Humpel, C.3
-
15
-
-
33750936038
-
Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent
-
Thurmann PA, Haack S, Werner U et al. Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent. Clin Pharmacol Ther 2006;80:551-3.
-
(2006)
Clin Pharmacol Ther
, vol.80
, pp. 551-553
-
-
Thurmann, P.A.1
Haack, S.2
Werner, U.3
-
16
-
-
3343026223
-
UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver
-
Epub mar 25
-
Court MH, Hao Q, Krishnaswamy S et al. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver. J Pharmacol Exp Ther 2004;310:656-65. Epub 2004 mar 25.
-
(2004)
J Pharmacol Exp Ther 2004
, vol.310
, pp. 656-665
-
-
Court, M.H.1
Hao, Q.2
Krishnaswamy, S.3
-
17
-
-
0031661580
-
The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis
-
Godfrey C, Sweeney K, Miller K et al. The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis. Br J Clin Pharmacol 1998;4:369-76.
-
(1998)
Br J Clin Pharmacol
, vol.4
, pp. 369-376
-
-
Godfrey, C.1
Sweeney, K.2
Miller, K.3
-
18
-
-
0034945769
-
Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome
-
Drici MD, Clement N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 2001:575-85.
-
(2001)
Drug Saf
, pp. 575-585
-
-
Drici, M.D.1
Clement, N.2
-
19
-
-
0034821658
-
Gender and the placebo analgesic effect in acute pain
-
Averbuch M, Katzper M. Gender and the placebo analgesic effect in acute pain. Clin Pharmacol Ther 2001;70:287-91.
-
(2001)
Clin Pharmacol Ther
, vol.70
, pp. 287-291
-
-
Averbuch, M.1
Katzper, M.2
-
20
-
-
0035863170
-
No gender differences in placebo responses of patients with major depressive disorder
-
Casper RC, Tollefson GD, Nilsson ME. No gender differences in placebo responses of patients with major depressive disorder. Biol Psychiatry 2001;49:158-60.
-
(2001)
Biol Psychiatry
, vol.49
, pp. 158-160
-
-
Casper, R.C.1
Tollefson, G.D.2
Nilsson, M.E.3
-
21
-
-
0029617264
-
French pharmacovigilance database system: Examples of utilisation
-
Moore N, Noblet C, Kreft-Jais C et al. French pharmacovigilance database system: examples of utilisation. Therapie 1995;50:557-62.
-
(1995)
Therapie
, vol.50
, pp. 557-562
-
-
Moore, N.1
Noblet, C.2
Kreft-Jais, C.3
-
22
-
-
33645278345
-
Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: Are there differences between males and females?
-
Light KP, Lovell AT, Butt H et al. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females? Pharmacoepidemiol Drug Saf 2006;15:151-60.
-
(2006)
Pharmacoepidemiol Drug Saf
, vol.15
, pp. 151-160
-
-
Light, K.P.1
Lovell, A.T.2
Butt, H.3
|